FRAX Underestimates Fracture Risk in specific high-risk groups 

FRAX Underestimates Fracture Risk in specific high-risk groups 

A recent study evaluated the performance of the Fracture Risk Assessment Tool (FRAX) in predicting major osteoporotic fractures (MOF) and hip fractures among older adults with diabetes. Utilizing data from the Kaiser Permanente Northern California Diabetes Registry, researchers analyzed 96,914 patients aged 65 years or older over a mean follow-up of 4.3 years. During this period, 5.6% experienced MOF, and 1.8% sustained hip fractures. ​ 

Overall, FRAX demonstrated good discrimination, with area under the receiver operating curve (AUC) values of 0.72 for MOF and 0.77 for hip fractures. However, the tool underpredicted fracture risk in certain high-risk groups. Notably, Hispanic women exhibited observed-to-predicted (O/P) ratios of 1.8 for MOF and 1.5 for hip fractures, indicating significant underestimation. Similarly, Black men had O/P ratios of 1.8 for MOF and 1.3 for hip fractures. Additionally, patients with a diabetes duration of 20 years or more showed an O/P ratio of 1.6 for MOF. ​ 

The study also found that fracture risk increased with age and longer diabetes duration. For instance, MOF rates rose from 3.2% in patients aged 65-69 years to 11.2% in those aged 85-89 years. Discrimination accuracy declined in patients aged 75 years or older, with AUC values dropping below 0.70. While women had higher fracture rates than men, the discrimination performance of FRAX was similar between genders. ​ 

These findings suggest that while FRAX is a useful tool for assessing fracture risk in older adults with diabetes, it may not fully capture the risk in specific subgroups, particularly Hispanic women, Black men, and those with prolonged diabetes duration. The researchers recommend that in cases where FRAX may be inadequate, clinical judgment and consideration of diabetes, specific risk factors such as fall risk, insulin use, and other complications, should guide decisions regarding bone density screening and osteoporosis treatment. ​ 

Read the article here!

Join the FFN

To help make the FFN vision a reality in your country, join the FFN – for free – today
Join FFN Today